Bigora Sian's Form 4/A amendment
AmendedProcessa Pharmaceuticals, Inc. (PCSA) · filed May 19, 2026
- Accession no.
- 0000897069-26-001154
- Filed
- May 19, 2026
- Trade date
- Apr 30, 2026
- Filing delay
- 19 days
- Rule 10b5-1 plan
- Not checked
- Original filed
- May 1, 2026
This filing lists 1 non-derivative transaction. Open-market purchases total $5.34K. It was filed 19 days after the trade.
This amendment replaces 0000897069-26-001000 (filed May 1, 2026).
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Bigora SianCIK 0001799365 | Officer (Chief Development Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 30, 2026 | Common Stock | PPurchaseAcquired | +1,971 | $2.71F1 | +$5,341.41 | 7,481 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Shares adjusted to correct immaterial errors.
Referenced by the price of 1 transaction in Table I.